First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver: Interaction with bile acid transport systems
- 12 July 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (1) , 85-96
- https://doi.org/10.1016/0006-2952(96)00141-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Transepithelial Transport Properties of Peptidomimetic Thrombin Inhibitors in Monolayers of a Human Intestinal Cell Line (Caco-2) and Their Correlation to in Vivo DataPharmaceutical Research, 1995
- Design and Synthesis of Potent and Highly Selective Thrombin InhibitorsJournal of Medicinal Chemistry, 1994
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of Thrombus Growth in Experimental Models of ThrombosisThrombosis and Haemostasis, 1992
- HMG‐CoA Reductase Inhibitors: An Exciting Development in the Treatment of HyperlipoproteinemiaMedicinal Research Reviews, 1991
- Clinical Implications of New Drugs for Lowering Plasma Cholesterol ConcentrationsDrugs, 1991
- Intestinal uptake of dipeptides and β-lactam antibiotics. I. The intestinal uptake system for dipeptides and β-lactam antibiotics is not part of a brush border membrane peptidaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Design of rat renin inhibitory peptidesJournal of Medicinal Chemistry, 1988
- Design of peptide hormone and neurotransmitter analoguesTrends in Pharmacological Sciences, 1985
- Peptide factors as pharmaceuticals: Criteria for applicationBiopolymers, 1983